Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of 7MW4911 in advanced solid tumors
CTR20254163Phase 2Active
- Sponsor
- Maiwei Biotech
- Start
- Nov 2025
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 7MW4911 in Nonhematologic neoplasms, sponsored by Maiwei Biotech. Started Nov 2025; status: active.
02
Drugs
7MW4911
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20254163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254163.